222 related articles for article (PubMed ID: 8575531)
1. The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes.
Campbell AD; Womer DE; Simon JR
Eur J Pharmacol; 1995 Jul; 290(2):157-62. PubMed ID: 8575531
[TBL] [Abstract][Full Text] [Related]
2. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
[TBL] [Abstract][Full Text] [Related]
3. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
5. O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
Madras BK; Reith ME; Meltzer PC; Dutta AK
Eur J Pharmacol; 1994 Apr; 267(2):167-73. PubMed ID: 8050478
[TBL] [Abstract][Full Text] [Related]
6. Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi.
Tarazi FI; Tomasini EC; Baldessarini RJ
Neurosci Lett; 1998 Sep; 254(1):21-4. PubMed ID: 9780082
[TBL] [Abstract][Full Text] [Related]
7. Drug interactions with the dopamine transporter in cryopreserved human caudate.
Eshleman AJ; Wolfrum K; Mash DC; Christensen K; Janowsky A
J Pharmacol Exp Ther; 2001 Feb; 296(2):442-9. PubMed ID: 11160629
[TBL] [Abstract][Full Text] [Related]
8. The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus.
Niznik HB; Fogel EF; Fassos FF; Seeman P
J Neurochem; 1991 Jan; 56(1):192-8. PubMed ID: 1987318
[TBL] [Abstract][Full Text] [Related]
9. Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum.
Marshall JF; O'Dell SJ; Navarrete R; Rosenstein AJ
Neuroscience; 1990; 37(1):11-21. PubMed ID: 2243588
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
Valchar M; Hanbauer I
J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
[TBL] [Abstract][Full Text] [Related]
11. Characterization of dopamine transporter and locomotor effects of cocaine, GBR 12909, epidepride, and SCH 23390 in C57BL and DBA mice.
Womer DE; Jones BC; Erwin VG
Pharmacol Biochem Behav; 1994 Jun; 48(2):327-35. PubMed ID: 8090798
[TBL] [Abstract][Full Text] [Related]
12. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.
Wu Q; Reith ME; Kuhar MJ; Carroll FI; Garris PA
J Neurosci; 2001 Aug; 21(16):6338-47. PubMed ID: 11487657
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
14. Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen.
Izenwasser S; Newman AH; Katz JL
Eur J Pharmacol; 1993 Oct; 243(2):201-5. PubMed ID: 8276070
[TBL] [Abstract][Full Text] [Related]
15. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.
Baumann MH; Ayestas MA; Dersch CM; Rothman RB
Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249
[TBL] [Abstract][Full Text] [Related]
16. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine.
Izenwasser S; Coy AE; Ladenheim B; Loeloff RJ; Cadet JL; French D
Eur J Pharmacol; 1999 Jun; 373(2-3):187-93. PubMed ID: 10414438
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
[TBL] [Abstract][Full Text] [Related]
18. Clobenpropit, a histamine H
Mena-Avila E; Márquez-Gómez R; Aquino-Miranda G; Nieto-Alamilla G; Arias-Montaño JA
Pharmacol Rep; 2018 Feb; 70(1):146-155. PubMed ID: 29414147
[TBL] [Abstract][Full Text] [Related]
19. Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration.
King GR; Xiong Z; Ellinwood EH
Eur J Pharmacol; 1999 Jan; 364(2-3):79-87. PubMed ID: 9932709
[TBL] [Abstract][Full Text] [Related]
20. Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes.
Billaud G; Costentin J; Bonnet JJ
Eur J Pharmacol; 1993 Nov; 247(3):333-40. PubMed ID: 8307105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
